Takeda takes pole position in norovirus vaccine development

Tracy Staton Cruise ships, take heart. Takeda Pharmaceuticals is leading the efforts to develop a vaccine against norovirus, the vomiting bug that has crippled pleasure ships and afflicted ...

Biomérieux Receives CE Marking for VIDAS 3, the New Generation of VIDAS

barbara.lempert Marcy l’Étoile, France, June 20, 2013 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIDAS® 3, the new generation of VIDAS®, ...

With lead drug from Pfizer, Esperion shares jump in expanded $70M biotech IPO

Ryan McBride Esperion Therapeutics got a warm reception after an upsized IPO that hauled in $ 70 million. The Plymouth, MI-based biotech company increased the offering size from 4.5 ...

Novartis says asthma blockbuster Xolair also effective against serious hives

Eric Palmer Novartis says its asthma drug Xolair can help those who suffer from chronic spontaneous urticaria, a particularly nasty form of hives. If approved, it would add some sales ...

Novo Nordisk All-Diabetes Team Gears Up

barbara.lempert Team Novo Nordisk, the world’s first all-diabetes professional athletic team, is Changing Diabetes® in Toronto, Vancouver MISSISSAUGA, ON, June 26, 2013 ...

Takeda takes aim at new vomiting-bug vaccine

John Carroll his experimental vaccine combines components of two types of norovirus, which Takeda believes should provide an effective guard against all the viral strains in circulation. FierceBiotech ...

Spain sugarcoats pharma-purchasing medicine with payment guarantee

Tracy Staton Spain is back at the pharma-cuts drawing board. After the industry balked at a centralized pricing plan late last year, the government is circling back to the same plan–but ...

FDA Attempts To Shutter A Compounding Pharmacy For Good

esilverman In the latest ‘get tough’ move by the FDA against wayward compounding pharmacies, the agency has filed a lawsuit seeking a permanent injunction against a New ...

Roche, AstraZeneca join forces on precompetitive R&D initiative

John Carroll Roche and AstraZeneca have formed an unusual, precompetitive alliance designed to share vast stockpiles of compound data in order to improve their chances of success in ...

Sanofi, Novartis, GlaxoSmithKline reportedly circling India’s Elder Pharma

Tracy Staton It's early days for Elder Pharmaceuticals' sell-or-not analysis. But the Indian media antennae are out for the latest tremor of news. Today, the Economic Times ...

DTC Ads Say What? Check The Fine Print, If You Can Read It

esilverman Everyone knows the old saying about checking the fine print. And there is plenty of fine print in many of the printed ads for prescription drugs, of course. But ...

Delcath slashes U.S. staff by 20% after FDA-panel disaster

Ryan McBride The Queensbury, NY-based company plans to fire 20% of its U.S. workforce to conserve cash and concentrate resources in Europe, where the company has CE mark clearance for ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS